Male Birth Control Gel: Phase 2 Trials
For decades, the burden of hormonal contraception has fallen almost exclusively on women. While men have been limited to condoms or vasectomies, science is finally closing the gap with a new transdermal solution. The development of a male birth control gel, specifically the formulation known as NES/T, has shown significant promise in Phase 2 clinical trials. This hormonal gel, applied daily to the shoulders, offers a reversible and effective alternative that could reshape family planning.
Understanding the NES/T Gel
The gel currently making headlines is developed by the National Institutes of Health (NIH), specifically the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), in partnership with the Population Council. It is not a simple testosterone cream. Instead, it is a combination drug that balances two distinct hormones to achieve contraception without ruining a man’s libido.
The Two Active Ingredients
The gel relies on a precise chemical balance:
- Segesterone Acetate (Nestorone): This is a progestin. Its primary job is to block natural testosterone production in the testes. By shutting down this production, it effectively stops the body from producing sperm.
- Testosterone: Because the progestin shuts down natural testosterone production, a man’s blood levels of the hormone would drop to unhealthy levels without a supplement. The testosterone in the gel replaces what the body would naturally make. This ensures that muscle mass, sex drive, and other male characteristics remain normal while sperm production remains suppressed.
Results from Phase 2 Clinical Trials
The recent Phase 2b trials have been pivotal in proving that this concept works in the real world. The study involved couples from various international sites, including the United States, the United Kingdom, Sweden, Kenya, Italy, and Chile. The goal was to determine how fast the gel works and how effectively it prevents pregnancy.
Speed of Suppression
One of the major concerns with male hormonal birth control is the “lag time.” Unlike a condom which works instantly, hormonal methods require time to alter biology. The Phase 2 data presented at recent Endocrine Society meetings showed encouraging results regarding speed.
- Rapid Action: While previous estimates suggested it might take three to four months to lower sperm counts, the trial data indicated that many men achieved suppression much faster.
- The Threshold: The goal is to reach a sperm count of fewer than 1 million per milliliter. In the general population, a fertile count is anywhere from 15 million to over 200 million per milliliter.
- Success Rate: By week 15 of the trial, approximately 86% of participants had reached the necessary suppression levels to prevent pregnancy.
Efficacy in Couples
Once sperm counts dropped to the suppression threshold, couples participating in the study were instructed to use the gel as their only form of birth control for a year. The results suggested high efficacy, with pregnancy rates comparable to, or potentially better than, typical use of male condoms. This phase is critical because it moves the science from “does it lower sperm?” to “does it actually prevent babies?”
How the Gel is Applied
The application method is designed to be as non-invasive as possible to encourage daily compliance. It functions similarly to hand sanitizer but is applied to a different part of the body.
The user pumps a specific dose of the gel (roughly the size of a quarter or a teaspoon) into their hand. They apply it to each shoulder and upper arm. The shoulders are chosen because the skin there absorbs the hormones efficiently, and it is an area less likely to come into direct contact with others immediately after application.
Users are advised to let the gel dry completely before getting dressed or showering. This usually takes just a few minutes. The transdermal delivery system allows the hormones to enter the bloodstream steadily throughout the day, avoiding the peaks and troughs often associated with oral medications or injections.
Side Effects and Safety Profile
No medication is without side effects. However, the Phase 2 trials suggest that the NES/T gel is generally well-tolerated. Because the formulation includes replacement testosterone, many of the side effects associated with low testosterone (like fatigue or loss of libido) are avoided.
Reported side effects generally included:
- Skin Irritation: Dryness or rash at the application site on the shoulders.
- Weight Gain: Mild fluctuations in weight were noted in some participants.
- Libido Changes: While the testosterone replacement is meant to stabilize sex drive, some men reported increased libido, while a smaller number reported a decrease.
- Acne: Hormonal shifts can occasionally trigger breakouts.
Crucially, the side effects reported were not severe enough to cause a mass dropout of trial participants. This adherence is a strong indicator that the product is viable for long-term consumer use.
Reversibility: A Key Factor
The most significant advantage of this gel over a vasectomy is reversibility. Phase 2 trials have confirmed that once a man stops using the gel, his sperm production recovers.
The recovery timeline varies by individual. For most participants, sperm levels returned to the fertile range within four months of stopping the treatment. This confirms the gel’s viability as a family planning tool for men who may want children in the future but need contraception now.
The Path to Pharmacy Shelves
Despite the success of Phase 2, you cannot yet ask your doctor for this prescription. The drug must undergo Phase 3 trials, which involve thousands of participants and provide the definitive safety and efficacy data required by the FDA.
Following Phase 3, the developers must find a commercial partner to manufacture and market the drug. Licensing discussions are likely ongoing, but realistically, this product is several years away from commercial availability. However, the successful completion of Phase 2 proves that male chemical contraception is biologically possible and socially acceptable to many couples.
Frequently Asked Questions
Does the gel protect against STIs? No. Like the pill or the IUD for women, the male birth control gel protects only against pregnancy. Condoms are still necessary for protection against sexually transmitted infections.
Will the gel transfer to a female partner? There is a minor risk of transfer if a partner touches the wet gel immediately after application. However, users are instructed to cover the application site with clothing after the gel dries. Studies show that once the area is washed or covered, the risk of transferring hormones to a partner or child is negligible.
Does it kill sperm? No, it does not kill existing sperm. It signals the testes to stop producing new sperm. This is why there is a lag time before it becomes effective; the body must clear out the sperm that were already produced before the treatment began.
Why has this taken so long to develop? Biological and regulatory hurdles are higher for male contraception. Because men do not bear the physical risks of pregnancy, the FDA and other regulatory bodies have a very low tolerance for side effects in male contraceptives. The treatment must be incredibly safe to be approved for healthy men.
Can I join a trial? Recruitment for these studies happens in waves. Interested individuals should monitor the ClinicalTrials.gov database or the NICHD website for announcements regarding upcoming Phase 3 trials for the NES/T gel.